Transforming growth factor‐β messaging: #ContextMatters
Open Access
- 8 November 2020
- journal article
- editorial
- Published by Wiley in British Journal of Dermatology
- Vol. 184 (4), 592-593
- https://doi.org/10.1111/bjd.19607
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Heterogeneous addiction to transforming growth factor-beta signalling in recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinomaBritish Journal of Dermatology, 2021
- On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?Frontiers in Cell and Developmental Biology, 2020
- Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic PerspectivesInternational Journal of Molecular Sciences, 2019
- Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosaMatrix Biology, 2019
- The role of TGFβ in wound healing pathologiesMechanisms of Ageing and Development, 2018
- Targeting TGF-β Signaling in CancerTrends in Cancer, 2017
- Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 casesOrphanet Journal of Rare Diseases, 2016
- Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanismsEMBO Molecular Medicine, 2015
- TGFβ signalling in contextNature Reviews Molecular Cell Biology, 2012
- TGF-β signaling in cancer – a double-edged swordTrends in Cell Biology, 2001